Application 220493
- Type
- ANDA
- Sponsor
- ANTHEA PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.25% | No | No |
| 002 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.5% | No | No |
| 003 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.75% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220493-001 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | |
| A220493-002 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | |
| A220493-003 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220493-001 | AP |
| A220493-002 | AP |
| A220493-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220493-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A220493-002 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A220493-003 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | NorthStar RxLLC | ee3b5bbe-4013-4682-b6ee-db86e7788077 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 562f4499-f3b7-4d9e-b022-61172176c883 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 2c6f9b85-e783-4ad4-a804-a0ff1a32ec2c | 2026-06-24 | Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Sportpharm LLC | 6f9ebeef-350a-495e-a0bf-c335ab48bf1c | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 8f8f4ece-de78-4c13-8d9f-c3bb7053019d | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | bb44c7e1-d911-4788-908f-09b7b271969b | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 0e552e3a-cf52-4d74-9381-6cc1b29b4c90 | 2026-04-04 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 02a845c3-4521-4926-e397-25ab536e7cf6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Marvona-25 SUIK | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | cb71b757-057e-42d4-8a12-8fd8e69a9124 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Brookfield Pharmaceuticals, LLC. | e8b32972-6984-4f1c-e053-2995a90a3277 | 2026-01-13 | Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | ProPharma Distribution | 42c973e2-307b-924c-e063-6394a90a737a | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | ProPharma Distribution | 3f7ab295-6429-4760-e063-6294a90a781f | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| bupivacaine hydrochloride | BUPIVACAINE HYDROCHLORIDE | Northstar Rx LLC | adadc041-8d5e-4bf8-a89b-e227729a880d | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | bupivacaine hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Sensorcaine | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 2046d833-2974-42fd-a29e-7fc1dc7166cc | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | ONESOURCE SPECIALTY PHARMA LIMITED | 5c10e3a1-7806-40c7-afd2-4c420e141823 | 2025-11-28 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | ONESOURCE SPECIALTY PHARMA LIMITED | 02d0e5f1-5fab-4420-b673-785fd81d7ae2 | 2025-11-28 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Sensorcaine MPF | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 78c6789d-773e-4b26-90bd-34a6b6d730ce | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Sensorcaine | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 100201ad-6e4d-4e91-8b5c-621d0bf0dcc2 | 2025-11-07 | Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc | 3c0f567f-b7f8-4ee8-bfb2-61cd82550498 | 2025-10-30 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc | 496ccd9e-d1c3-4b5a-93b6-0c457faa1589 | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.